Schw Us S-Cp

Clark Ian T, Director of Guardant Health Inc., Plans to Sell Stocks

Renaissance initiates coverage on SanDisk with a Buy rating and $322 target price

Guardant Health to showcase liquid biopsy data at San Antonio Breast Cancer Symposium

Norwegian Bank Increases Stake in BridgeBio Pharma to 1.02%

SanDisk Director Necip Sayiner Reports Disposition of Company Common Stock

Rocket Companies Director Disposes of Common Stock

Rosenblatt Raises Lumentum Holding's Target Price to $380

Rhumbline Advisers cut holdings in Revolution Medicines in Q2

Legal & General Group Increased Stake in BridgeBio Pharma

Guardant Health insiders sold $5.846 million worth of shares

Guardant Health Exec Monroe Terilyn J Sells $5.8M in Shares

Ionis Pharmaceuticals Director Sold Company Common Stock

NextPower Expands Majorly in Tennessee

TD Cowen Analyst Maintains Buy Rating on Revolution Medicines

NextPower Inc CFO Sells Company Common Stock

Matthew Rizik Reports Disposition of Rocket Companies Inc. Common Stock

Ionis Pharmaceuticals Receives FDA Breakthrough Therapy Designation

Morgan Stanley Raises SanDisk's Target Price and Maintains Overweight Rating

Revolution Medicines insider Mark Goldsmith sells stocks

Ionis Pharmaceuticals Director Disposes of Company Common Stock

Treasure Gbl

SMX Security Matters

Wheeler Real Estate

DigitalBridge

Toro

Dreamland

Lichen

Springview

Alumis

Top Kingwin

Rocket Cos. Inc. stock fell 1.86% to $19.03 on Friday, underperforming compared to competitors despite a positive market session. The stock is 15.63% below its 52-week high and has seen four consecutive days of losses. Trading volume was significantly below its 50-day average.

Dow Jones

Rocket

Rocket Cos. Inc. Stock Underperforms Friday When Compared To Competitors

Clark Ian T, Director of Guardant Health Inc, filed a Form 144 with the SEC to sell 28,611 shares on December 5, 2025. The sale will be conducted through Charles Schwab & Co Inc. Form 144 is required for selling restricted stock, allowing sales within 90 days of filing.

Reuters

Guardant Health

Dir Clark Files To Sell 28,611 Of Guardant Health Inc [GH]

Officer Chris Freeman of Guardant Health Inc filed a Form 144 with the SEC to sell 31,452 restricted shares on December 5, 2025. The sale will be brokered by Charles Schwab & Co Inc. Form 144 is required for selling restricted stock, allowing the owner to sell within 90 days of filing.

Officer Freeman Files To Sell 31,452 Of Guardant Health Inc [GH]

Michael Brian Bell, CFO of Guardant Health Inc, filed a Form 144 with the SEC to sell 80,362 shares on December 5, 2025. The sale will be conducted through Charles Schwab & Co Inc. Filing Form 144 is a prerequisite for selling restricted stock, allowing the sale within 90 days of filing.

CFO Bell Files To Sell 80,362 Of Guardant Health Inc [GH]

SNDK

Memory stocks, including Micron, Seagate, Western Digital, and Sandisk, are rebounding after steep declines in November due to AI credit risk and speculative momentum downturns. Micron, Western Digital, and Seagate are close to reclaiming all-time highs, while Sandisk lags behind. The demand for memory chips in data centers supports this recovery.

- Memory stocks are experiencing a strong performance this week, with notable gains in shares of Micron, Seagate Technology, Western Digital, and Sandisk.  
- These stocks had previously dropped around 20% due to credit risks in AI and a decline in speculative momentum stocks, particularly affecting Sandisk.  
- Currently, Micron, Western Digital, and Seagate are close to their all-time highs, while Sandisk has recovered the least, highlighting the ongoing demand for memory chips in data centers.  

Sherwoodnews

Sandisk

Micron Tech

Seagate Tech

Western Digital

Memory stocks soar as AI supporting cast repairs damage from steep November declines

Rocket Companies chairman Dan Gilbert joins 'Squawk Box' to discuss the housing affordability crisis in the U.S., state of the economy, the Fed's interest rate outlook, impact of AI, and more.

Rocket Companies' Dan Gilbert on housing affordability: The only thing that solves it is supply

LITE

Lumentum Holdings rose 3.71% in pre-market; SMX Security Matters rose 100.00% in pre-market; Wheeler Real Estate rose 76.82% in pre-market; Dreamland rose 55.88% in pre-market

Tracking Unusual Activity

Lumentum

Pre-market hot trades in US stocks: Rosenblatt raises target price, Lumentum pre-market up 3.71% attracting market attention

BBIO

Norges Bank acquired 1,956,654 shares of BridgeBio Pharma, valued at $84,488,000, in the second quarter, owning 1.02% of the company. Other investors also adjusted their stakes. BridgeBio's stock opened at $74.76, with a market cap of $14.41 billion. Analysts have given the stock a "Moderate Buy" rating with a consensus price target of $74.37. Recent insider trading includes sales by Director Frank Mccormick and CEO Neil Kumar.

Market Beat

Bridgebio Pharma

Norges Bank Purchases New Holdings in BridgeBio Pharma, Inc. $BBIO

Guardant Health will present 14 abstracts at the 2025 San Antonio Breast Cancer Symposium, showcasing advancements in liquid biopsy tests for breast cancer. The presentations will highlight the efficacy of Guardant Reveal and Guardant360 Liquid in detecting cancer recurrence and monitoring treatment response. These studies demonstrate the potential of blood-based testing to guide treatment decisions and improve patient management across various stages of breast cancer.

StockTitan

Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium | GH Stock News

Guardant Health, Inc.'s common stock is subject to a lock-up agreement ending on December 5, 2025. The lock-up period lasts 31 days, from November 4 to December 5, 2025. During this time, directors and executive officers cannot sell or transfer shares without consent from Goldman Sachs & Co. LLC and Jefferies LLC, with specified exceptions.

marketscreener

Certain Common Stock of Guardant Health, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025.

Sayiner Necip Director of SanDisk Corp [SNDK] filed a Form 4 on December 4, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/3/25TransactionSaleShares1,271Price$195.14Value$248,027Ending Holdings: 3,479 - DirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Dir Sayiner Sells 1,271 ($248K) Of SanDisk Corp [SNDK]

SanDisk Director Necip Sayiner has reported the disposal of common shares of the company. The full filing is available via EDGAR, the SEC's system. This news brief was created by Public Technologies using AI and is for informational purposes only.

SanDisk Director Necip Sayiner Reports Disposal of Common Shares